Anastrozole: first-line therapy for advanced breast cancer?

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1270, 2001-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carboplatin: first-line therapy for ovarian cancer?

By  

Inpharma, Vol. 1, Iss. 1352, 2002-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Aromatase inhibitors: the new first-line therapy in breast cancer?

By  

Inpharma, Vol. 1, Iss. 1265, 2000-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Anastrozole of global value in early breast cancer?

By  

Inpharma, Vol. 1, Iss. 1422, 2004-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Anastrozole of global value in early breast cancer?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 445, 2004-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Is it worth using lapatinib for advanced breast cancer?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 555, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite